{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:25:27Z","timestamp":1759422327577},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bjoms.2015.10.036","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T09:45:57Z","timestamp":1457689557000},"page":"501-505","source":"Crossref","is-referenced-by-count":12,"title":["Epidemiological study of alendronate-related osteonecrosis of the jaw in the southeast of Scotland"],"prefix":"10.1016","volume":"54","author":[{"given":"Stephanie","family":"Sammut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Malden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjoms.2015.10.036_bib0110","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw - - 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1601-0825.2009.01568.x","article-title":"Bisphosphonate-related osteonecrosis: genetic and acquired risk factors","volume":"15","author":"Sarasquete","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tripleo.2010.04.023","article-title":"Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers","volume":"110","author":"Fleisher","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0145","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0150","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0155","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study","volume":"66","author":"Wessel","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0160","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bjoms.2014.11.008","article-title":"United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosis","volume":"53","author":"Rogers","year":"2015","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0170","unstructured":"National Records of Scotland. Mid-2010 population estimates Scotland: population estimates by sex, age and administrative area. 2011. Available from URL: http:\/\/www.gro-scotland.gov.uk\/files\/statistics\/population-estimates\/mid-2010\/mid-year-pop-est-2010.pdf"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0175","unstructured":"Merck Online Newsroom. Statement by Merck regarding FOSAMAX\u00ae (alendronate sodium) and rare cases of osteonecrosis of the jaw. 2010. Available from URL: http:\/\/www.merck.com\/newsroom\/news-release-archive\/product\/fosamax_statement.html"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00198-012-2013-y","article-title":"Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures","volume":"24","author":"Lapi","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.joms.2013.06.221","article-title":"Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate","volume":"72","author":"Ulmner","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0190","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1038\/sj.bdj.2013.327","article-title":"A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital","volume":"214","author":"Taylor","year":"2013","journal-title":"Br Dent J"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00774-011-0299-z","article-title":"An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence","volume":"30","author":"Malden","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0200","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ejim.2013.05.011","article-title":"Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases","volume":"24","author":"Di Fede","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1746-160X-8-5","article-title":"Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws","volume":"8","author":"Conte-Neto","year":"2012","journal-title":"Head Face Med"},{"key":"10.1016\/j.bjoms.2015.10.036_bib0210","unstructured":"DataPharm. Electronic Medicines Compendium: Alendronic acid. 2012. Available from URL: http:\/\/www.medicines.org.uk\/emc\/medicine\/25809\/SPC\/Alendronic+Acid+10+mg+Tablets\/#PHARMACOLOGICAL_PROPS"}],"container-title":["British Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435616000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435616000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T07:21:08Z","timestamp":1536909668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0266435616000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0266435616000796"],"URL":"https:\/\/doi.org\/10.1016\/j.bjoms.2015.10.036","relation":{},"ISSN":["0266-4356"],"issn-type":[{"value":"0266-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}